Integrins in cancer: biological implications and therapeutic opportunities
By J. Desgrosellier, D. Cheresh. Nature Reviews. Cancer, 2010
3,622 citations recorded by the source corpus.
The integrin family of cell adhesion receptors regulates a diverse array of cellular functions crucial to the initiation, progression and metastasis of solid tumours. The importance of integrins in several cell types that affect tumour progression has made them an appealing target for cancer therapy. Integrin antagonists, including the αvβ3 and αvβ5 inhibitor cilengitide, have shown encouraging activity in Phase II clinical trials and cilengitide is currently being tested in a Phase III trial in patients with glioblastoma. These exciting clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.
Subfields: Immunology, Immunology and Allergy, Oncology
View Paper: https://www.semanticscholar.org/paper/acf11375c001308ec88fc59b211e51a713d1a719
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Immunology and Allergy
- Rakesh K. Jain
- Peter Carmeliet
- Valerie M. Weaver
- C. Mas-Moruno
- F. Rechenmacher
- Horst Kessler
- T. Cox
- Jonathan M Cooper
In Oncology
Citations in the corpus
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation (2010, background): “The combination of the integrins expressed on a given cell dictates to what extent the cell will adhere to and migrate on different matrices [7].”
- Drug Resistance in Cancer: An Overview (2014, background): “Selectin and other cell adhesion receptors, which interact with the extracellular matrix and cell adhesion receptors of stromal cells, also participate in the process of EMT and cell survival [83–87] (Figure 2).”
- Molecular mechanisms and clinical applications of angiogenesis (2011, background): “Integrins are heterodimeric receptors that mediate adhesion to ECM and immunoglobulin superfamily molecule”
- Treating metastatic cancer with nanotechnology (2011, positive): “Likewise, short peptides, including those with integrin-binding domains RGD and IKVAV, can be appended to nanoparticles and can increase their binding to specific cell types within a tissu”
- Targeting of drugs and nanoparticles to tumors (2010, background): “A prime example is the overexpression of v3 and v5 integrins in angiogenic vessels (Brooks et al., 1994; Erdreich-Epstein et al., 2000; Desgrosellier and Cheresh, 2010).”
- Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment (2019, neutral): “on Tumor Cells Integrin expression on tumor cells themselves has been associated with tumor progression and metastasis by increasing the proliferation, survival, migration and invasion of the malignant cells (199).”
- Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. (2010, background): “Taken together these results not only strengthen the hypothesis that integrin activation is crucial in EOC progression [65,66], but also open up new avenues to explore complex aspects of cancer celleECM interactions using this versatile 3D platform.”
- The delivery of therapeutic oligonucleotides (2016, background): “While many integrins are rather ubiquitously expressed, there are several examples of tissue or disease state selective expression including alphaIIbbeta3 on platelets, beta2 integrins in leukocytes and alphavbeta3 expression in angiogenic endothelia and in certain tumors (92,93).”
- Dynamic interplay between the collagen scaffold and tumor evolution (2010, background): “Integrins are strong contenders for linking collagen and cancer cell differentiation [41].”
- Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions (2017, background): “The interactions between tumors and their extracellular matrix play a critical role in tumor cell growth, motility and invasiveness indicating the potential effect of modulating these interactions [48,49].”